Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation);Lignes directrices pour la détection, la prise en charge et la prévention de l'hyperbilirubinémie chez les nouveau-nés à terme et peu prématurés (35 semaines d'âge gestationnel ou plus)

Paediatrics and Child Health

Volumn 12, Issue SUPPL. B, 2007, Pages

[No Author Info available]

Author keywords

35 weeks' gestation; Hyperbilirubinemia; Jaundice; Preterm newborn; Term newborn

Indexed keywords

AGAR; BILIRUBIN; IMMUNOGLOBULIN;

BREAST FEEDING EDUCATION; CLINICAL FEATURE; COCHRANE LIBRARY; GESTATION PERIOD; HUMAN; HYPERBILIRUBINEMIA; JAUNDICE; LABORATORY TEST; MEDLINE; PHOTOTHERAPY; PRACTICE GUIDELINE; PREMATURITY; PROGNOSIS; REVIEW; RISK FACTOR;

EID: 34548451566     PISSN: 12057088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (95)

1. Hansen TW. Mechanisms of bilirubin toxicity: Clinical implications. Clin Perinatol 2002;29:765-778,viii.
2. Newman TB, Maisels MJ. Evaluation and treatment of jaundice in the term newborn: A kinder, gentler approach. Pediatrics 1992;89(5 Pt 1):809-18.
3. Volpe JJ. Neurology of the Newborn, 4th Edition. Philadelphia: WB Saunders, 2001.
4. American Academy of Pediatrics, Subcommittee on Neonatal Hyperbilirubinemia. Neonatal jaundice and kernicterus. Pediatrics 2001;108:763-5.
5. Penn AA, Enzmann DR, Hahn JS, Stevenson DF. Kernicterus in a full term infant. Pediatrics 1994;93(6 Pt 1):1003-6.
6. Maisels MJ, Newman TB. Kernicterus in otherwise healthy, breastfed term newborns. Pediatrics 1995;96(4 Pt 1):730-3.
7. Stevenson DK, Fanaroff AA, Maisels MJ, et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics 2001;108:31-9.
8. Harris MC, Bernbaum JC, Polin JR, Zimmerman R, Polin RA. Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia. Pediatrics 2001;107:1075-80.
9. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999;103:6-14.
10. Bhutani VK, Johnson LH, Maisels JM, et al. Kernicterus: Epidemiological strategies for its prevention through systems-based approaches. J Perinatol 2004;24:650-62.
11. American Academy of Pediatrics, Subcommittee on Neonatal Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297-316. (Erratum in 2004;114:1138)
12. Ip S, Glicken S, Kulig J, et al. Management of Neonatal Hyperbilirubinemia. Evidence Report/Technology Assessment No. 65 (Prepared by Tufts-New England Medical Center Evidence-based Practice Center under Contract No. 290-97-0019). AHRQ Publication No. 03-E011. Rockville, MD: US Department of Health and Human Services, Agency for Healthcare Research and Quality, 2003. (Version current at March 22, 2007).
13. Ohlsson A. Neonatal jaundice: Continuing concern and need for research. Pediatr Res 2001;50:674-5.
14. Hintz SR, Stevenson DK. Just when you thought it was safe. Pediatr Res 2001;50:676-7.
15. Sarici SU, Serdar MA, Korkmaz A, et al. Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns. Pediatrics 2004;113:775-80.
16. Ip S, Chung M, Kulig J, et al; American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics 2004;114:e130-53.
17. Johnson LH, Bhutani VK, Brown AK. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr 2002;140:396-403.
18. Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ 2006;175:587-90.
19. Centers for Disease Control and Prevention (CDC). Kernicterus in full term infants - United States, 1994-1998. MMWR Morb Mortal Wkly Rep 2001;50:491-4.
20. Maisels MJ, Newman TB. Jaundice in full-term and near-term babies who leave the hospital within 36 hours. The pediatrician's nemesis. CHn Perinatol 1998;25:295-302.
21. Ebbesen F. Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr 2000;89:1213-7.
22. Dennery PA, Seidman DS, Stevenson DK. Neonatal hyperbilirubinemia. N Engl J Med 2001;344:581-90.
23. Soorani-Lunsing I, Woltil HA, Hadders-Algra M. Are moderate degrees of hyperbilirubinemia in healthy term neonates really safe for the brain? Pediatr Res 2001;50:701-5.
24. Seidman DS, Ergaz Z, Paz I, et al. Predicting the risk of jaundice in full-term healthy newborns: A prospective population-based study. J Perinatol 1999;19(8 Pt 1):564-7.
25. Haynes RB, McKibbon KA, Wilczynski NL, Walter SD, Werre SR; Hedges Team. Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: Analytical survey. BMJ 2005;330:1179.
26. Oxford Centre for Evidence-Based Medicine. (Version current at March 28, 2007).
27. Newman TB, Liljestrand P, Escobar GJ. Combining clinical risk factors with serum bilirubin levels to predict hyperbilirubinemia in newborns. Arch Pediatr Adolesc Med 2005;159:113-9.
28. Sarici SU, Yurdakok M, Serdar MA, et al. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility. Pediatrics 2002;109:e53.
29. Carbonell X, Botet F, Figueras J, Riu-Godo A. Prediction of hyperbilirubinaemia in the healthy term newborn. Acta Paediatr 2001:90:166-70.
30. Madlon-Kay DJ. The clinical significance of ABO blood group incompatibility. Arch Fam Med 1993;2:285-7.
31. Ozolek JA, Watchko JF, Mimouni F. Prevalence and lack of clinical significance of blood group incompatibility in mothers with blood type A or B. J Pediatr 1994:125:87-91.
32. Newman TB, Easterling MJ, Goldman ES, Stevenson DK. Laboratory evaluation of jaundice in newborns. Frequency, cost, and yield. Am J Dis Child 1990:144:364-8. (Erratum in 1992;146:1420-1)
33. Dinesh D. Review of positive direct antiglobulin tests found on cord blood sampling. J Paediatr Child Health 2005:41:504-7.
34. Leistikow EA, Collin MF, Savastano GD, de Sierra TM, Leistikow BN. Wasted health care dollars. Routine cord blood type and Coombs' testing. Arch Pediatr Adolesc Med 1995:149:1147-51.
35. Madan A, Huntsinger K, Burgos A, Benitz WE. Readmission for newborn jaundice: The value of the Coombs' test in predicting the need for phototherapy. Clin Pediatr (Phila) 2004;43:63-8.
36. Madlon-Kay DJ. Identifying ABO incompatibility in newborns: Selective vs automatic testing. J Fam Pract 1992;35:278-80.
37. Kaplan M, Herschel M, Hammerman C, Karrison T, Hoyer JD, Stevenson DK. Studies in hemolysis in glucose-6-phosphate dehydrogenase-deficient African American neonates. Clin Chim Acta 2006;365:177-82.
38. Meloni T, Forteleoni G, Dore A, Cutillo S. Neonatal hyperbilirubinaemia in heterozygous glucose-6-phosphate dehydrogenase deficient females. Br J Haematol 1983;53:241-6.
39. Kaplan M, Beutler E, Vreman HJ, et al. Neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient heterozygotes. Pediatrics 1999;104(1 Pt 1):68-74.
40. Gourley GR, Kreamer B, Arend R. The effect of diet on feces and jaundice during the first 3 weeks of life. Gastroenterology 1992;103:660-7.
41. Riskin A, Kugelman A, Abend-Weinger M, Green M, Hemo M, Bader D. In the eye of the beholder: How accurate is clinical estimation of jaundice in newborns? Acta Paediatr 2003;92:574-6. (Erratum in 2005;94:1168)
42. Bhutani VK, Gourley GR, Adler S, Kreamer B, Dalin C, Johnson LH. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics 2000;106:e17.
43. Madlon-Kay DJ. Recognition of the presence and severity of newborn jaundice by parents, nurses, physicians, and icterometer. Pediatrics 1997;100:E3.
44. Stevenson DK, Fanaroff AA, Maisels MJ, et al. Prediction of hyperbilirubinemia in near-term and term infants. J Perinatol 2001;21(Suppl 1):S63-72.
45. Riskin A, Abend-Weinger M, Bader D. How accurate are neonatologists in identifying clinical jaundice in newborns? Clin Pediatr (Phila) 2003;42:153-8.
46. Eggert LD, Wiedmeier SE, Wilson J, Christensen RD. The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system. Pediatrics 2006;117:c855-62.
47. Watchko JF. Vigintiphobia revisited. Pediatrics 2005;115:1747-53.
48. Leslie GI, Philips JB III, Cassady G. Capillary and venous bilirubin values. Are they really different? Am J Dis Child 1987;141:1199-200.
49. Amato M, Huppi P, Markus D. Assessment of neonatal jaundice in low birth weight infants comparing transcutaneous, capillary and arterial bilirubin levels. Eur J Pediatr 1990;150:59-61.
50. Rubaltelli FF, Gourley GR, Loskamp N, et al. Transcutaneous bilirubin measurement: A multicentre evaluation of a new device. Pediatrics 2001;107:1264-71.
51. Cremer RJ, Perryman PW, Richards DH. Influence of light on the hyperbilirubinaemia of infants. Lancet 1958;1:1094-7.
52. Rubaltelli FF, Carli M. The effect of light on cutaneous bilirubin. Biol Neonate 1971;18:457-62.
53. Maisels MJ, Ostrea EM Jr, Touch S, et al. Evaluation of a new transcutaneous bilirubinometer. Pediatrics 2004:113:1628-35.
54. Hansen TW. Recent advances in the pharmacotherapy for hyperbilirubinaemia in the neonate. Expert Opin Pharmacother 2003;4:1939-48.
55. Ahlfors CE. Unbound bilirubin associated with kernicterus: A historical approach. J Pediatr 2000;137:540-4.
56. Funato M, Tamai H, Shimada S, Nakamura H. Vigintiphobia, unbound bilirubin, and auditory brainstem responses. Pediatrics 1994:93:50-3.
57. Nakamura H, Yonetani M, Uetani Y, Funato M, Lee Y. Determination of serum unbound bilirubin for prediction of kernicterus in low birthweight infants. Acta Paediatr Jpn 1992;34:642-7.
58. McDonagh AF, Maisels MJ. Bilirubin unbound: Deja vu all over again? Pediatrics 2006;117:523-5.
59. Venigalla S, Gourley GR. Neonatal cholestasis. Semin Perinatol 2004;28:348-55.
60. Butler DA, MacMillan JP. Relationship of breast feeding and weight loss to jaundice in the newborn period: Review of the literature and results of a study. Cleve Clin Q 1983;50:263-8.
61. Keffler S, Kelly DA, Powell JE, Green A. Population screening for neonatal liver disease: A feasibility study. J Pediatr Gastroenterol Nutr 1998;27:306-11.
62. Powell JE, Keffler S, Kelly DA, Green A. Population screening for neonatal liver disease: Potential for a community-based programme. J Med Screen 2003;10:112-6.
63. Maisels MJ, Gifford K. Breast-feeding, weight loss, and jaundice. J Pediatr 1983;102:117-8.
64. Bader D, Yanir Y, Kugelman A, Wilhelm-Kafil M, Riskin A. Induction of early meconium evacuation: Is it effective in reducing the level of neonatal hyperhilirubinemia? Am J Perinatol 2005;22:329-33.
65. Chen JY, Ling UP, Chen JH. Early meconium evacuation: Effect on neonatal hyperbilirubinemia. Am J Perinatol 1995;12:232-4.
66. Nicoll A, Ginsburg R, Tripp JH. Supplementary feeding and jaundice in newborns. Acta Pediatr Scand 1982;71:759-61.
67. Perez EM, Cooper TR, Moise AA, Ferry GD, Weisman LE. Treatment of obstructive jaundice in erythroblastosis fetalis with ursodeoxycholic acid (UDCA): A case report. J Perinatol 1998;18:317-9.
68. Lindenbaum A, Hernandorena X, Vial M, et al. [Clofihrate for the treatment of hyperbilirubinemia in neonates born at term: A double blind controlled study (author's transl)]. Arch Fr Pediatr 1981;38(Suppl 1):867-73.
69. Murki S, Dutta S, Narang A, Sarkar U, Garewal G. A randomized, triple-blind, placebo-controlled trial of prophylactic oral phenobarbital to reduce the need for phototherapy in G6PD-deficient neonates. J Perinatol 2005;25:325-30.
70. Kappas A, Drummond GS, Valaes T. A single dose of Sn-mesoporphyrin prevents development of severe hyperhilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns. Pediatrics 2001;108:25-30. 71.
71. Valaes T, Drummond GS, Kappas A. Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production, Sn-mesoporphyrin. Pediatrics 1998;101:E1.
72. Kappas A, Drummond GS, Manola T, Petmezaki S, Valaes T. Sn-protoporphyrin use in the management of hyperbilirubinemia in term newborns with direct Coombs-positive ABO incompatibility. Pediatrics 1988;81:485-97.
73. Yaseen H, Khalaf M, Rashid N, Darwich M. Does prophylactic phototherapy prevent hyperbilirubinemia in neonates with ABO incompatibility and positive Coombs' test? J Perinatol 2005;25:590-4.
74. Warshaw JB, Gagliardi J, Patel A. A comparison of fluorescent and nonfluorescent light sources for phototherapy. Pediatrics 1980;65:795-8.
75. Vogl TP. Phototherapy of neonatal hyperbilirubinemia: Bilirubin in unexposed areas of the skin. J Pediatr 1974;85:707-10.
76. Seidman DS, Moise J, Ergaz Z, et al. A new blue light-emitting phototherapy device: A prospective randomized controlled study. J Pediatr 2000;136:771-4.
77. Sisson TR, Kendall N, Shaw E, Kechavarz-Oliai L. Phototherapy of jaundice in the newborn infant. II. Effect of various light intensities. J Pediatr 1972:81:35-8.
78. Casiday RE, Wright CM, Panter-Brick C, Parkinson KN. Do early infant feeding patterns relate to breast-feeding continuation and weight gain? Data from a longitudinal cohort study. Eur J Clin Nutr 2004;58:1290-6.
79. Messner KH, Maisels MJ, Leure-DuPree AE. Phototoxicity to the newborn primate retina. Invest Ophthalmol Vis Sci 1978;17:178-82.
80. Brown AK, Kim MH, Wu PY, Bryla DA. Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics 1985;75(2 Pt 2):393-400.
81. Mills JF, Tudehope D. Fibreoptic phototherapy for neonatal jaundice. Cochrane Database Syst Rev 2001;(1):CD002060.
82. BiliTool. (Version current at March 5, 2007).
83. Kemper K, Forsyth B, McCarthy P Jaundice, terminating breast-feeding, and the vulnerable child. Pediatrics 1989;84:773-8.
84. Tan KL. Decreased response to phototherapy for neonatal jaundice in breast-fed infants. Arch Pediatr Adolesc Med 1998;152:1187-90.
85. Martinez JC, Maisels MJ, Otheguy L, et al. Hyperbilirubinemia in the breast-fed newborn: A controlled trial of four interventions. Pediatrics 1993;91:470-3.
86. Alcock GS, Liley H. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates. Cochrane Database Syst Rev 2002;(3):CD003313.
87. Miqdad AM, Abdelbasit OB, Shaheed MM, Seidahmed MZ, Abomelha AM, Arcala OP. Intravenous immunoglobulin G (IVIG) thetapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn. J Matern Fetal Neonatal Med 2004;16:163-6.
88. Sutesh GK, Martin CL, Soil RF. Metalloporphyrins for treatment of unconjugated hyperbilirubinemia in neonates. Cochrane Database Syst Rev 2003;(2):CD004207.
89. Mehta S, Kumar P, Narang A. A randomized controlled trial of fluid supplementation in term neonates with severe hyperbilirubinemia. J Pediatr 2005;147:781-5.
90. Boo NY, Lee HT. Randomized controlled trial of oral versus intravenous fluid supplementation on serum bilirubin level during phototherapy of term infants with severe hyperbilirubinaemia. J Paediatr Child Health 2002;38:151-5.
91. Horvath A, Koletzko B, Kalisz M, Szajewska H. The effect of supplemental fluids or feedings during the first days of life on the success and duration of breastfeeding: A systematic review of randomized controlled trials. Arch Pediatr Adolesc Med 2005;159:597-8.
92. Odell GB, Gutcher GR, Whitmgton PF, Yang G. Enteral administration of agar as an effective adjunct to phototherapy of neonatal hypetbilirubinemia. Pediatr Res 1983:17:810-4.
93. Kemper K, Horwitz RI, McCarthy P. Decreased neonatal serum bilirubin with plain agar: A meta-analysis. Pediatrics 1988;82:631-8.
94. Caglayan S, Candemir H, Aksit S, Kansoy S, Asik S, Yaptak I. Superiority of oral agar and phototherapy combination in the treatment of neonatal hyperbilirubinemia. Pediatrics 1993;92:86-9.
95. Ebbesen F, Moller J. Agar ingestion combined with phototherapy in jaundiced newborn infants. Biol Neonate 1977;31:7-9.